Bortezomib

VELCADE®

Overview

Bortezomib is used to treat multiple myeloma and mantle cell lymphoma. It is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Bortezomib is given as an injection under the skin (subcutaneously) or injected into a vein through an IV.

SparkCures ID 1
Developed By Takeda Oncology
Brand Name Velcade®
Generic Name Bortezomib
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Verified
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myelom...
COBRA
View Trial
Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER
View Trial
Verified
Phase 3, Randomized Study comparing Bortezomib, Lenolidomide, and Dexamethasone (VRd) followed by an investigational CAR-T versus VRd followed by Lenalidomid...
CARTITUDE-5
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
View Trial
Verified
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Partic...
TTI-622
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480
View Trial
Verified
Phase 1b/2a Clinical Trial Studying the Safety and Optimal Dose of Iberdomide by Itself and in Combination with Other Approved Treatments in Multiple Myeloma
IBERDOMIDE
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma With Upfront Daratumumab-based Therapy
View Trial
DARA RVD For High Risk SMM
PRISM
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
ISATUXIMAB
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
View Trial
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
Standard Doses of Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or ...
View Trial
Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma
MAGROLIMAB
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
MAJESTEC-2
View Trial
Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myelom...
COBRA
View Trial
Verified
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (ADVANCE)
ADVANCE
View Trial
Verified
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480
View Trial
Verified
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
DREAMM9
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE ...
EQUATE
View Trial
Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma With Upfront Daratumumab-based Therapy
View Trial
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma
ISATUXIMAB
View Trial
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myelom...
ISATUXIMAB
View Trial
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly Newly Diagnosed ...
View Trial
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
MILESTONE
View Trial
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
MAJESTEC-2
View Trial
Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in P...
EXCALIBER
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480
View Trial
Verified
Phase 1b/2a Clinical Trial Studying the Safety and Optimal Dose of Iberdomide by Itself and in Combination with Other Approved Treatments in Multiple Myeloma
IBERDOMIDE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma
MAGROLIMAB
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
MAJESTEC-2
View Trial
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...
SUCCESSOR-1
View Trial
Verified
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratum...
MAJESTEC-3
View Trial
Verified
A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...
DREAMM8
View Trial
Verified
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Partic...
TTI-622
View Trial
Verified
A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in...
CC-92480
View Trial
Verified
Phase 1b/2a Clinical Trial Studying the Safety and Optimal Dose of Iberdomide by Itself and in Combination with Other Approved Treatments in Multiple Myeloma
IBERDOMIDE
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating...
View Trial
Standard Doses of Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or ...
View Trial
Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma
MAGROLIMAB
View Trial
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
IINNOVATE-2
View Trial
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
MAJESTEC-2
View Trial
Smoldering Myeloma

The following is a listing of clinical trials for patients with Smoldering Myeloma.

DARA RVD For High Risk SMM
PRISM
View Trial
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.